Skip to main content
Caplight Logo









Bodymatter, Inc.

Bodymatter, Inc.

Private
Newport Beach, CaliforniaHealthcare & Life Scienceshttps://www.bodymatter.io/

Last Round

Seed

Feb 10, 2022

Total Funding Raised

$3M

Company Overview

Bodymatter, Inc. is a health technology company that develops mobile applications for sleep tracking and heart rate monitoring.

Sector

Healthcare & Life Sciences

Verticals

Sports & Fitness, Health IoT, Medical AI, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Keywords

sleep trackingheart rate monitoringwearable technologyhealth tracking apppersonalized health insightssubscription SaaSdigital healthAI health coachmHealthmobile healthsnore detectionbiohackinghealth IoTquantified selfprecision health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bodymatter, Inc. Comparables

Compare Bodymatter, Inc. with similar companies based on industry and business-model similarity.

Bodymatter, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tantsissa Holdings Pty Ltd
88%
Neybox Digital Ltd
84%
Enerjoy
84%

Bodymatter, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 10, 2022

Key People

Founding team and executive leadership

Eugene Spiritus

Co-Founder and Chief Medical Officer

Founding Team

Ryan Archdeacon

CEO & Co-Founder

Founding Team

Bodymatter, Inc. Investors

Notable investors and investment history

Bodymatter, Inc. investors
InvestorRounds
Surlamer InvestmentsSeed
Keshif VenturesSeed
K5 VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors grew 12,236% MoM, from 11 to 1.4K.

  • Feb 10, 2022

    $3M round with participation from Surlamer Investments and K5 Ventures.

Bodymatter, Inc. Filings

Explore SEC and related filing metadata, where available.

Bodymatter, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bodymatter, Inc.'s valuation, stock price, and market status.

Is Bodymatter, Inc. a public or private company?

Bodymatter, Inc. is a private company.

What is the current stock price of Bodymatter, Inc.?

Bodymatter, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Bodymatter, Inc. worth (valuation)?

Valuation information for Bodymatter, Inc. is not publicly available.

Can I buy Bodymatter, Inc. stock?

Bodymatter, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bodymatter, Inc.'s last funding round?

Bodymatter, Inc.'s most recent funding round was Seed on February 10, 2022.

Who are the main investors in Bodymatter, Inc.?

Key investors in Bodymatter, Inc. include Surlamer Investments, Keshif Ventures.

Will Bodymatter, Inc. IPO soon?

No public IPO plans have been announced for Bodymatter, Inc..

How can I track Bodymatter, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bodymatter, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewport Beach, California
Employee Range12
Year Founded2016
Last FundingFeb 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?